Shares of AngioDynamics, Inc. (NASDAQ:ANGO) are up Thursday after the biotechnology company raised guidance for four key financial metrics and shared positive sales performance for this past quarter.
AngioDynamics, Inc. (NASDAQ:ANGO) posted stronger-than-expected first-quarter results across its Med-Tech businesses and lifted its fiscal 2026 guidance. First-quarter revenue rose 12.1% to $75.7 ...
Hosted on MSN
H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance
AngioDynamics, Inc. (NASDAQ:ANGO) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential. On October 6, H.C. Wainwright reiterated its Buy rating on AngioDynamics (NASDAQ ...
Lake Street Capital started coverage on shares of AngioDynamics (NASDAQ:ANGO – Free Report) in a research note issued to investors on Wednesday, MarketBeat.com reports. The firm issued a buy rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback